Carcinogenesis Advance Access published online on August 18, 2006
Carcinogenesis, doi:10.1093/carcin/bgl143
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan
* To whom correspondence should be addressed. Recent efforts have been aimed at targeting the hypoxia inducible factor (HIF)-mediated hypoxia induced gene pathway for renal cell carcinomas (RCC) therapy. Among the various genes induced by HIF, vascular endothelial growth factor (VEGF) is one of the critical mediators in angiogenesis, tumor growth, and metastasis. To date, however, limited information is available on the functional differences regarding VEGF transcription between the HIF subunits, namely HIF-1
Received March 15, 2006
Revised July 21, 2006
Accepted August 1, 2006
CANCER BIOLOGY
Renal cancer cells lacking hypoxia inducible factor (HIF)-1
Toshiaki Shinojima 1, Mototsugu Oya 1 *, Atsushi Takayanagi 2, Ryuichi Mizuno 1, Nobuyoshi Shimizu 2, and Masaru Murai 1
expression maintain vascular endothelial growth factor expression through HIF-2
2 Department of Molecular Biology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan
Mototsugu Oya, E-mail: moto-oya{at}sc.itc.keio.ac.jp
Abstract 
and HIF-2. To investigate the HIF-1 and HIF-2 dependent effect on VEGF gene induction in RCC, a panel of human RCC cell lines was analyzed. We found that a loss of HIF-1 protein expression was a common event in RCC cell lines, which was associated not only with truncated HIF-1 mRNA transcripts but also with transcriptional silencing. Since the CpG rich promoter region of the HIF-1 gene contained a similar frequency of methylated CpG dinucleotides in RCC cell lines, a complex and non-uniform mechanism may be involved in this phenomenon. In these HIF-1 defective cell lines, the knockdown of the HIF-2 gene demonstrated that HIF-2 regulated the VEGF production, irrespective of the VHL gene mutation status. In contrast, HIF-1 played a predominant role in VEGF secretion in the cells expressing both wild-type HIF-1 and HIF-2 proteins. HIF-1 may therefore represent an important target molecule for RCC therapy, however, HIF-2 should be targeted in HIF-1 defective renal cancer cells.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Tsukamoto, S. Okada, Y. Onami, Y. Sasaki, K. Umezawa, and Y. Kawakami Impairment of Plasmacytoid Dendritic Cells for IFN Production by the Ligand for Immunoglobulin-Like Transcript 7 Expressed on Human Cancer Cells Clin. Cancer Res., September 15, 2009; 15(18): 5733 - 5743. [Abstract] [Full Text] [PDF]
|
|